Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Immunology|August 26, 2019
Is generation of C3(H2O) necessary for activation of the alternative pathway in real life?Kristina N Ekdahl, Camilla Mohlin, Anna Adler, et al.Clinical and Experimental Rheumatology|April 6, 2021
Rheumatoid arthritis autoantibodies and their association with age and sexEleftheria Pertsinidou, Vivek Anand Manivel, Helga Westerlind, et al.Science and Technology of Advanced Materials|December 15, 2022
Impact of spontaneous liposome modification with phospholipid polymer-lipid conjugates on protein interactionsHaruna Suzuki, Anna Adler, Tianwei Huang, et al.Lupus|August 4, 2020
High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patientsSahwa Elbagir, Amir I Elshafie, Elnour M Elagib, et al.Lupus|May 7, 2021
Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLESahwa Elbagir, Giorgia Grosso, NasrEldeen A Mohammed, et al.Annals of the Rheumatic Diseases|December 5, 2023
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammationEleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 25, 2025
A new principle to attenuate ischemia-reperfusion injury in kidney transplantationAli-Reza Biglarnia, Yuji Teramura, Sana Asif, et al.Blood Advances|July 10, 2023
Complement and platelets: prothrombotic cell activation requires membrane attack complex-induced release of danger signalsMarco Mannes, Veronika Pechtl, Susanne Hafner, et al.Science Advances|August 17, 2022
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101Panagiotis Skendros, Georgios Germanidis, Dimitrios C Mastellos, et al.Pageof 2